
Global Initiative Seeks 1,000 New Cancer Models
The effort will use next-generation cell-culture methods and fresh patient samples
The effort will use next-generation cell-culture methods and fresh patient samples
Beatrice Alexandra Golomb, a professor of medicine at the University of California, San Diego, responds
An immune system booster called CAR-T appears to cause lethal brain injury
The active ingredients are encapsulated in nanoparticles, which prevent the chemicals from seeping into the body
Federal officials expect it will take several years to collect needed genetic information from more than 1 million volunteers
Medicare saved $165 million in states with medical cannabis, study says
As opioid addiction soars, biotech companies eye a genetic mutation in people who feel no pain
How you talk could reveal heart disease or concussions, say researchers and companies developing the novel technology
But housing ultraclean lab rodents with “dirty” mice from pet stores could help
The US Centers for Disease Control and Prevention (CDC) points to new data showing the spray was ineffective from 2013 to 2016
The worst outbreak in decades has killed hundreds, and vaccine supplies are precarious
Miniature simulations allow scientists to study physiological mechanisms and behaviors in ways never before possible, creating opportunities for drug development
When immune cells rush to the site of a mosquito bite, viruses hijack the cells and turn them into viral factories—in mice, at least. Christopher Intagliata reports.
An NIH-backed vaccine is among several heading for human trials, but the timeline for large-scale deployment remains murky
New method could help anticancer drugs reach brain tumors
14 samples collected between January 2015 and May 2016 tested positive for a strain of the virus
Economists, investors and medical insurers can’t figure out how to pay for cutting-edge drugs
Firms chase a new breed of advanced veterinary care, from antibodies to cell therapies
Every year graduating med students leave their futures up to an algorithm—so what happens afterwards?
The harmless virus could deliver medicine throughout the brain
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account